ArticleFuture oncology (London, England)2024

Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience.

Andrea Sbrana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.